Member Info for Rudey

I should have stated 'confirmed in our clinic.'

Exactly right KTRB. I understand their trials aren't quarantine clinic based as you imply.

Different tests moniman. They do not compete with each other - their results will probably be confirmed in our labs - if they get results of course.

Not cheeky snapper - simply a dividend payable to all shareholders - the more you have the more you get.

Antifragile, all my shares are in an ISA. Maybe your SIPP and ISA accounts are through different mm's?

I knew you were taking the plss barwick. But why did you find it necessary to take the plss, when my observation could have benefitted someone's decision making? Too many little Hitlers on this bb.

Can't get a price to buy £500. That means the market makers are short of stock and the price may be about to go up - for the slower learners amongst us - ie. barwick.

I clearly have more common sense than you barwick. It means they want shares, idiot.

to sell 500k - nearly £60k. Pretty unusual from my experience to get offered more than £15k in one transaction.

Indeed Swap....we rented a cottage at Lambs Head for a fortnight - spoke to a New Zealand back-packer who reckoned this little stretch of Ireland was the most beautiful place in the world.

Absolutely not Jiz. Market forces, and I believe they had a deadline to keep.
IMO

Jiz, I don't mind having a go.
Link had a significant shareholding in ORPH, and although it seems they had suggested to CF they were holding for the long term, they unloaded to Acacia who then dumped onto the open market.
CF stated that had they approached him their shareholding could have been bought by one of the many II's who wanted to participate in the placing, but it seems Acacia thought they would get a better return by selling to PI's on the open market. I'm sure they're right, but the consequence for the share price is clear to all.
IMO

Off topic - Swapleber, coincidentally I went through a suitcase yesterday with old clothes in it. I came across a t-shirt I bought from the Blind Piper in Caherdaniel a couple of miles from Waterville, on June 18th, 1994 - the night Ireland beat Italy 1-0 in the world cup. What a night, and the best holiday I've ever had.

This paragraph for me says it all:

'Employees are going to need to be reassured that their health and safety is being looked after by their employers. Employers have a legal duty of care over their employees, which they cannot afford to ignore. Prevention and detection will be the bywords that those with responsibility for health and safety will work by.'

I think you have a point Swap, but I don't think we can understate the need for secrecy on pricing, particularly when, let's face it, there is a market close to panic mode with cash to burn. These big companies must be looking at ways to stop losing money hand over fist, and if Open Orphan can help them through, they'll pay whatever it takes. However, if Open Orphan charge one company £90 per test, and another company have been offered £120, and they know of the first offer, they'll want £90 too. I'm sure you understand this - I'm not trying to teach a grandmother to suck eggs.
I agree that this recent deal with a top three pharma and the contract with Venn could perhaps have had a value provided. But maybe the other top three pharma we are about to do a deal with knows the content of the deal with the other company, and could use the price if it was disclosed to get a better deal.
We aren't far apart with our thinking, but I'm prepared to cut more slack for CF for a while longer.
Hopefully you'll get 4 bedrooms and a swimming pool, but why you'd want to live there when you've got County Kerry I don't know.

I'm not at all surprised tbh Bear666. It takes a few months to go from nothing to a multi million pound side-line in any business - once the equipment is in and the infrastructure is in place the key will be getting the contracts signed. 1,000 samples being tested a day provides £50,000 net profit per day, once the first 10,000 tests are completed. This is clearly a stage on the way to 3,000 tests per day and beyond.

A pretty naive post from you there Hallowed.

I think there's just a few impatient PI's. No big deal, apart from for them.

The II's who bought at 11p in the placing aren't likely to sell at 11.5p Hallowed. And they hold nearly all the shares.

There's a 500k share trade at 15.12 on the 18th Peter. Maybe someone's got their pounds and shares crossed on the other board?

I don't reckon Open Orphan will exist as a separate entity much after Christmas. By then, there will have been considerable revenue from Covid-19 challenge studies, antibody testing and the sale of Imutex. In addition will be the increased volume of non-Covid work, which I assume will cover all of the intervening running costs. Obviously CF won't want to sell the company with huge amounts of cash in the bank, so it will need to be paid out in the form of dividends, probably in portions.
Say we only get contracts for 6 Covid-19 challenge studies, with £8m revenue from each, sign contracts for 4 months of full capacity Covid-19 antibody tests (@ average of £50 net profit per test), and receive £200m from the sale of Imutex. If my back of a fag packet calculations and guesswork are anywhere near right we could receive a number of dividends totalling around 40p per share.
In addition there will be the sale proceeds of the company (obviously excluding Imutex), say £130m - 20p per share.
Any views?